Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Cortical superficial siderosis: A prospective observational cohort study.

Moulin S, Casolla B, Kuchcinski G, Boulouis G, Rossi C, Hénon H, Leys D, Cordonnier C.

Neurology. 2018 Jun 8. pii: 10.1212/WNL.0000000000005778. doi: 10.1212/WNL.0000000000005778. [Epub ahead of print]

PMID:
29884737
2.

Intravenous Recombinant Tissue-Type Plasminogen Activator: Influence on Outcome in Anterior Circulation Ischemic Stroke Treated by Mechanical Thrombectomy.

Ferrigno M, Bricout N, Leys D, Estrade L, Cordonnier C, Personnic T, Kyheng M, Henon H.

Stroke. 2018 Jun;49(6):1377-1385. doi: 10.1161/STROKEAHA.118.020490. Epub 2018 May 10.

PMID:
29748424
3.

Identification of a specific functional network altered in poststroke cognitive impairment.

Bournonville C, Hénon H, Dondaine T, Delmaire C, Bombois S, Mendyk AM, Cordonnier C, Moulin S, Leclerc X, Bordet R, Lopes R.

Neurology. 2018 May 22;90(21):e1879-e1888. doi: 10.1212/WNL.0000000000005553. Epub 2018 Apr 20.

PMID:
29678937
4.

Hippocampal Deformations and Entorhinal Cortex Atrophy as an Anatomical Signature of Long-Term Cognitive Impairment: from the MCAO Rat Model to the Stroke Patient.

Delattre C, Bournonville C, Auger F, Lopes R, Delmaire C, Henon H, Mendyk AM, Bombois S, Devedjian JC, Leys D, Cordonnier C, Bordet R, Bastide M.

Transl Stroke Res. 2018 Jun;9(3):294-305. doi: 10.1007/s12975-017-0576-9. Epub 2017 Oct 16.

PMID:
29034421
5.

In-hospital ischaemic stroke treated with intravenous thrombolysis or mechanical thrombectomy.

Caparros F, Ferrigno M, Decourcelle A, Hochart A, Moulin S, Dequatre N, Bodenant M, Hénon H, Cordonnier C, Leys D.

J Neurol. 2017 Aug;264(8):1804-1810. doi: 10.1007/s00415-017-8570-4. Epub 2017 Jul 15.

PMID:
28712001
6.

Are the results of intravenous thrombolysis trials reproduced in clinical practice? Comparison of observed and expected outcomes with the stroke-thrombolytic predictive instrument (STPI).

Decourcelle A, Moulin S, Dequatre-Ponchelle N, Bodenant M, Rossi C, Girot M, Hénon H, Wiel E, Bordet R, Goldstein P, Pruvo JP, Cordonnier C, Leys D.

Rev Neurol (Paris). 2017 Jun;173(6):381-387. doi: 10.1016/j.neurol.2017.03.023. Epub 2017 Apr 25.

PMID:
28454980
7.

STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease.

Sachdev PS, Lo JW, Crawford JD, Mellon L, Hickey A, Williams D, Bordet R, Mendyk AM, Gelé P, Deplanque D, Bae HJ, Lim JS, Brodtmann A, Werden E, Cumming T, Köhler S, Verhey FR, Dong YH, Tan HH, Chen C, Xin X, Kalaria RN, Allan LM, Akinyemi RO, Ogunniyi A, Klimkowicz-Mrowiec A, Dichgans M, Wollenweber FA, Zietemann V, Hoffmann M, Desmond DW, Linden T, Blomstrand C, Fagerberg B, Skoog I, Godefroy O, Barbay M, Roussel M, Lee BC, Yu KH, Wardlaw J, Makin SJ, Doubal FN, Chappell FM, Srikanth VK, Thrift AG, Donnan GA, Kandiah N, Chander RJ, Lin X, Cordonnier C, Moulin S, Rossi C, Sabayan B, Stott DJ, Jukema JW, Melkas S, Jokinen H, Erkinjuntti T, Mok VC, Wong A, Lam BY, Leys D, Hénon H, Bombois S, Lipnicki DM, Kochan NA; STROKOG.

Alzheimers Dement (Amst). 2016 Nov 18;7:11-23. doi: 10.1016/j.dadm.2016.10.006. eCollection 2017.

8.

Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.

Leys D, Hommet Y, Jacquet C, Moulin S, Sibon I, Mas JL, Moulin T, Giroud M, Sagnier S, Cordonnier C, Medeiros de Bustos E, Turc G, Ronzière T, Bejot Y, Detante O, Ouk T, Mendyk AM, Favrole P, Zuber M, Triquenot-Bagan A, Ozkul-Wermester O, Montoro FM, Lamy C, Faivre A, Lebouvier L, Potey C, Poli M, Hénon H, Renou P, Dequatre-Ponchelle N, Bodenant M, Debruxelles S, Rossi C, Bordet R, Vivien D; OPHELIE investigators and the STROKAVENIR network.

Neurology. 2016 Dec 6;87(23):2416-2426. Epub 2016 Nov 4.

PMID:
27815401
9.

Influence of Medication on Fatigue Six Months after Stroke.

Ponchel A, Labreuche J, Bombois S, Delmaire C, Bordet R, Hénon H.

Stroke Res Treat. 2016;2016:2410921. doi: 10.1155/2016/2410921. Epub 2016 Jun 19.

10.

Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study.

Moulin S, Labreuche J, Bombois S, Rossi C, Boulouis G, Hénon H, Duhamel A, Leys D, Cordonnier C.

Lancet Neurol. 2016 Jul;15(8):820-829. doi: 10.1016/S1474-4422(16)00130-7. Epub 2016 Apr 28.

PMID:
27133238
11.

The Behavioral and Cognitive Executive Disorders of Stroke: The GREFEX Study.

Roussel M, Martinaud O, Hénon H, Vercelletto M, Bindschadler C, Joseph PA, Robert P, Labauge P, Godefroy O; GREFEX Study Group.

PLoS One. 2016 Jan 29;11(1):e0147602. doi: 10.1371/journal.pone.0147602. eCollection 2016.

12.

Research Progresses in Understanding the Pathophysiology of Moyamoya Disease.

Bersano A, Guey S, Bedini G, Nava S, Hervé D, Vajkoczy P, Tatlisumak T, Sareela M, van der Zwan A, Klijn CJ, Braun KP, Kronenburg A, Acerbi F, Brown MM, Calviere L, Cordonnier C, Henon H, Thines L, Khan N, Czabanka M, Kraemer M, Simister R, Prontera P, Tournier-Lasserve E, Parati E; European Moyamoya Disease Initiative.

Cerebrovasc Dis. 2016;41(3-4):105-18. doi: 10.1159/000442298. Epub 2016 Jan 12. Review.

13.

Multiple Simultaneous Spontaneous Intracerebral Hemorrhages: A Rare Entity.

Chen Y, Hénon H, Bombois S, Pasquier F, Cordonnier C.

Cerebrovasc Dis. 2016;41(1-2):74-9. doi: 10.1159/000442475. Epub 2015 Dec 16.

PMID:
26671248
14.

Prognostic Factors for Cognitive Decline After Intracerebral Hemorrhage.

Benedictus MR, Hochart A, Rossi C, Boulouis G, Hénon H, van der Flier WM, Cordonnier C.

Stroke. 2015 Oct;46(10):2773-8. doi: 10.1161/STROKEAHA.115.010200. Epub 2015 Aug 13.

15.

Factors Associated with Poststroke Fatigue: A Systematic Review.

Ponchel A, Bombois S, Bordet R, Hénon H.

Stroke Res Treat. 2015;2015:347920. doi: 10.1155/2015/347920. Epub 2015 May 25. Review.

16.

Which factors influence the resort to surrogate consent in stroke trials, and what are the patient outcomes in this context?

Mendyk AM, Labreuche J, Henon H, Girot M, Cordonnier C, Duhamel A, Leys D, Bordet R.

BMC Med Ethics. 2015 Apr 24;16:26. doi: 10.1186/s12910-015-0018-8.

17.

Influence of neurologists' experience on the outcome of patients treated by intravenous thrombolysis for cerebral ischaemia.

Tuffal A, Moulin S, Dequatre-Ponchelle N, Bodenant M, Dumont F, Lefebvre C, Hénon H, Debette S, Cordonnier C, Leys D.

J Neurol. 2015 May;262(5):1209-15. doi: 10.1007/s00415-015-7693-8. Epub 2015 Mar 6.

PMID:
25740665
18.

Surgical management of Moyamoya disease and syndrome: Current concepts and personal experience.

Thines L, Petyt G, Aguettaz P, Bodenant M, Himpens FX, Lenci H, Henon H, Gauthier C, Hossein-Foucher C, Cordonnier C, Lejeune JP.

Rev Neurol (Paris). 2015 Jan;171(1):31-44. doi: 10.1016/j.neurol.2014.08.007. Epub 2014 Dec 30. Review.

PMID:
25555850
19.

Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study.

Paciaroni M, Inzitari D, Agnelli G, Caso V, Balucani C, Grotta JC, Sarraj A, Sung-Il S, Chamorro A, Urra X, Leys D, Henon H, Cordonnier C, Dequatre N, Aguettaz P, Alberti A, Venti M, Acciarresi M, D'Amore C, Zini A, Vallone S, Dell'Acqua ML, Menetti F, Nencini P, Mangiafico S, Barlinn K, Kepplinger J, Bodechtel U, Gerber J, Bovi P, Cappellari M, Linfante I, Dabus G, Marcheselli S, Pezzini A, Padovani A, Alexandrov AV, Shahripour RB, Sessa M, Giacalone G, Silvestrelli G, Lanari A, Ciccone A, De Vito A, Azzini C, Saletti A, Fainardi E, Orlandi G, Chiti A, Gialdini G, Silvestrini M, Ferrarese C, Beretta S, Tassi R, Martini G, Tsivgoulis G, Vasdekis SN, Consoli D, Baldi A, D'Anna S, Luda E, Varbella F, Galletti G, Invernizzi P, Donati E, De Lodovici ML, Bono G, Corea F, Sette MD, Monaco S, Riva M, Tassinari T, Scoditti U, Toni D.

J Neurol. 2015 Feb;262(2):459-68. doi: 10.1007/s00415-014-7550-1. Epub 2014 Dec 2.

PMID:
25451851
20.

Long-term follow-up study of endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis trial.

Mas JL, Arquizan C, Calvet D, Viguier A, Albucher JF, Piquet P, Garnier P, Viader F, Giroud M, Hosseini H, Hinzelin G, Favrole P, Hénon H, Neau JP, Ducrocq X, Padovani R, Milandre L, Rouanet F, Wolff V, Saudeau D, Mahagne MH, Sablot D, Amarenco P, Larrue V, Beyssen B, Leys D, Moulin T, Lièvre M, Chatellier G; EVA-3S Investigators.

Stroke. 2014 Sep;45(9):2750-6. doi: 10.1161/STROKEAHA.114.005671. Epub 2014 Jul 31.

21.

External validation of the MRI-DRAGON score: early prediction of stroke outcome after intravenous thrombolysis.

Turc G, Aguettaz P, Ponchelle-Dequatre N, Hénon H, Naggara O, Leclerc X, Cordonnier C, Leys D, Mas JL, Oppenheim C.

PLoS One. 2014 Jun 4;9(6):e99164. doi: 10.1371/journal.pone.0099164. eCollection 2014.

22.

Thrombolytic therapy for stroke in patients with preexisting cognitive impairment.

Murao K, Leys D, Jacquin A, Kitazono T, Bordet R, Béjot Y, Kimura K, Godefroy O, Wakisaka Y, Moulin S, Ago T, Sibon I, Bombois S, Mas JL, Hénon H, Pasquier F, Giroud M, Cordonnier C, Okada Y; OPHELIE-COG investigators.

Neurology. 2014 Jun 10;82(23):2048-54. doi: 10.1212/WNL.0000000000000493. Epub 2014 May 14.

PMID:
24827495
23.

Rate of intravenous thrombolysis for acute ischaemic stroke in the North-of-France region and evolution over time.

Dequatre-Ponchelle N, Touzani H, Banh A, Girard-Buttaz I, Coche R, Dobbelaere P, Cordonnier C, Girot M, Aguettaz P, Mounier-Vehier F, Wiel E, Bronet N, Josien E, Duhamel P, Mihout M, Maisonneuve A, Mackowiak A, Bodenant M, Williatte P, Leclerc X, Lefebvre C, Nigeon O, Devos P, Duncan G, Malanda G, Majed B, Dereeper O, Pégoraro V, Rosolacci T, Alarcon P, Koral E, Pasquini M, Verclytte S, N'Kuendjo JB, Campagne JB, Le Coz P, Devienne J, Seth Z, Tholliez R, Hénon H, Smith G, Dumont F, Agbemebia F, Behra JM, Pollet D, Coffin P, Lavau P, Vérier A, Lucas C, Smaiti N, Dalinval P, Dallongeville J, Valette P, Pruvo JP, Goldstein P, Leys D.

J Neurol. 2014 Jul;261(7):1320-8. doi: 10.1007/s00415-014-7344-5. Epub 2014 Apr 22.

PMID:
24752808
24.

Influence of cognitive impairment on the management of ischaemic stroke.

Murao K, Bombois S, Cordonnier C, Hénon H, Bordet R, Pasquier F, Leys D.

Rev Neurol (Paris). 2014 Mar;170(3):177-86. doi: 10.1016/j.neurol.2014.01.665. Epub 2014 Mar 6. Review.

PMID:
24613474
25.

Baseline serum glucose concentration and symptomatic haemorrhagic transformation in non-diabetic stroke patients treated by intravenous thrombolysis.

Gnofam M, Leys D, Ponchelle-Dequatre N, Bodenant M, Hénon H, Bordet R, Cordonnier C.

J Neurol. 2013 Nov;260(11):2786-92. doi: 10.1007/s00415-013-7069-x. Epub 2013 Aug 14.

PMID:
23942982
26.

Does pre-existing cognitive impairment no-dementia influence the outcome of patients treated by intravenous thrombolysis for cerebral ischaemia?

Murao K, Bodenant M, Cordonnier C, Bombois S, Hénon H, Pasquier F, Bordet R, Leys D.

J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1412-4. doi: 10.1136/jnnp-2013-305281. Epub 2013 Aug 2. No abstract available.

PMID:
23911949
27.

Incidence and predictors of late seizures in intracerebral hemorrhages.

Rossi C, De Herdt V, Dequatre-Ponchelle N, Hénon H, Leys D, Cordonnier C.

Stroke. 2013 Jun;44(6):1723-5. doi: 10.1161/STROKEAHA.111.000232. Epub 2013 May 2.

28.

Mortality in patients treated by intra-venous thrombolysis for ischaemic stroke.

Majhadi L, Leys D, Bodenant M, Hénon H, Bordet R, Cordonnier C.

J Neurol. 2013 Jun;260(6):1637-48. doi: 10.1007/s00415-013-6847-9. Epub 2013 Feb 7.

PMID:
23389413
29.

Vitamin K antagonists-associated cerebral hemorrhages: what are their characteristics?

Dequatre-Ponchelle N, Hénon H, Pasquini M, Rutgers MP, Bordet R, Leys D, Cordonnier C.

Stroke. 2013 Feb;44(2):350-5. doi: 10.1161/STROKEAHA.112.672303. Epub 2013 Jan 3.

30.

A very early neurological improvement after intravenous thrombolysis for acute cerebral ischaemia does not necessarily predict a favourable outcome.

Bodenant M, Debette S, Cordonnier C, Dumont F, Hénon H, Bordet R, Leys D.

Acta Neurol Belg. 2013 Mar;113(1):67-72. doi: 10.1007/s13760-012-0155-5. Epub 2012 Nov 21.

PMID:
23180467
31.

Heavy alcohol intake and intracerebral hemorrhage: characteristics and effect on outcome.

Casolla B, Dequatre-Ponchelle N, Rossi C, Hénon H, Leys D, Cordonnier C.

Neurology. 2012 Sep 11;79(11):1109-15. doi: 10.1212/WNL.0b013e3182698d00.

PMID:
22965674
32.

Decompressive surgery for malignant middle cerebral artery infarcts: the results of randomized trials can be reproduced in daily practice.

Lucas C, Thines L, Dumont F, Leclerc X, Riegel B, Cordonnier C, Fourrier F, Hénon H, Rousseaux M, Leys D, Lejeune JP.

Eur Neurol. 2012;68(3):145-9. Epub 2012 Jul 25.

PMID:
22832365
33.

Formation of quaternary stereogenic centers by NHC-Cu-catalyzed asymmetric conjugate addition reactions with Grignard reagents on polyconjugated cyclic enones.

Tissot M, Poggiali D, Hénon H, Müller D, Guénée L, Mauduit M, Alexakis A.

Chemistry. 2012 Jul 9;18(28):8731-47. doi: 10.1002/chem.201200502. Epub 2012 Jun 11.

PMID:
22689205
34.

Is the frontal dysexecutive syndrome due to a working memory deficit? Evidence from patients with stroke.

Roussel M, Dujardin K, Hénon H, Godefroy O.

Brain. 2012 Jul;135(Pt 7):2192-201. doi: 10.1093/brain/aws132. Epub 2012 May 24.

PMID:
22637543
35.

Influence of differences in case mix on the better outcome of smokers after intravenous thrombolysis for acute cerebral ischemia.

Moulin S, Padjen-Bogosavljevic V, Marichal A, Cordonnier C, Jovanovic DR, Gautier S, Hénon H, Beslac-Bumbasirevic L, Bordet R, Leys D.

Eur Neurol. 2012;67(3):178-83. doi: 10.1159/000334847. Epub 2012 Jan 28.

PMID:
22286144
36.

Intravenous thrombolysis for acute cerebral ischaemia in old stroke patients ≥ 80 years of age.

Boulouis G, Dumont F, Cordonnier C, Bodenant M, Leys D, Hénon H.

J Neurol. 2012 Jul;259(7):1461-7. doi: 10.1007/s00415-011-6359-4. Epub 2011 Dec 20.

PMID:
22183776
37.

Relationships between recent intraplaque hemorrhage and stroke risk factors in patients with carotid stenosis: the HIRISC study.

Turc G, Oppenheim C, Naggara O, Eker OF, Calvet D, Lacour JC, Crozier S, Guegan-Massardier E, Hénon H, Neau JP, Toussaint JF, Mas JL, Méder JF, Touzé E; HIRISC study investigators.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):492-9. doi: 10.1161/ATVBAHA.111.239335. Epub 2011 Nov 10.

38.

Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome.

De Herdt V, Dumont F, Hénon H, Derambure P, Vonck K, Leys D, Cordonnier C.

Neurology. 2011 Nov 15;77(20):1794-800. doi: 10.1212/WNL.0b013e31823648a6. Epub 2011 Oct 5.

PMID:
21975203
39.

Influence of lipid profiles on the risk of hemorrhagic transformation after ischemic stroke: systematic review.

Nardi K, Leys D, Eusebi P, Cordonnier C, Gautier S, Hénon H, Bordet R.

Cerebrovasc Dis Extra. 2011 Jan-Dec;1(1):130-41. doi: 10.1159/000335014. Epub 2011 Dec 29.

40.

What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?

Cordonnier C, Leys D, Dumont F, Deramecourt V, Bordet R, Pasquier F, Hénon H.

Brain. 2010 Nov;133(11):3281-9. doi: 10.1093/brain/awq246. Epub 2010 Sep 17.

PMID:
20852266
41.

Synthesis and biological activities of new di- and trimeric quinoline derivatives.

Broch S, Hénon H, Debaud AL, Fogeron ML, Bonnefoy-Bérard N, Anizon F, Moreau P.

Bioorg Med Chem. 2010 Oct 1;18(19):7132-43. doi: 10.1016/j.bmc.2010.07.029. Epub 2010 Jul 16.

PMID:
20800501
42.

Intravenous thrombolysis for acute cerebral ischaemia: comparison of outcomes between patients treated at working versus nonworking hours.

Bodenant M, Leys D, Debette S, Cordonnier C, Dumont F, Hénon H, Girot M, Lucas C, Devos D, Defebvre L, Deplanque D, Leclerc X, Bordet R.

Cerebrovasc Dis. 2010;30(2):148-56. doi: 10.1159/000316058. Epub 2010 Jun 10.

PMID:
20551630
43.

Intra-cerebral haemorrhages: are there any differences in baseline characteristics and intra-hospital mortality between hospitaland population-based registries?

Cordonnier C, Rutgers MP, Dumont F, Pasquini M, Lejeune JP, Garrigue D, Béjot Y, Leclerc X, Giroud M, Leys D, Hénon H.

J Neurol. 2009 Feb;256(2):198-202. doi: 10.1007/s00415-009-0030-3. Epub 2009 Mar 6.

PMID:
19271106
44.

Neurosurgical treatment for aneurysm remnants or recurrences after coil occlusion.

Lejeune JP, Thines L, Taschner C, Bourgeois P, Henon H, Leclerc X.

Neurosurgery. 2008 Oct;63(4):684-91; discussion 691-2. doi: 10.1227/01.NEU.0000325499.82876.6D.

PMID:
18981879
45.

Regiodivergent 1,4 versus 1,6 asymmetric copper-catalyzed conjugate addition.

Hénon H, Mauduit M, Alexakis A.

Angew Chem Int Ed Engl. 2008;47(47):9122-4. doi: 10.1002/anie.200803735. No abstract available.

PMID:
18925597
46.

Patent foramen ovale: detection with nongated multidetector CT.

Revel MP, Faivre JB, Letourneau T, Henon H, Leys D, Delannoy-Deken V, Remy-Jardin M, Remy J.

Radiology. 2008 Oct;249(1):338-45. doi: 10.1148/radiol.2491071874.

PMID:
18796685
47.

Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial.

Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H, Viguier A, Bossavy JP, Denis B, Piquet P, Garnier P, Viader F, Touzé E, Julia P, Giroud M, Krause D, Hosseini H, Becquemin JP, Hinzelin G, Houdart E, Hénon H, Neau JP, Bracard S, Onnient Y, Padovani R, Chatellier G; EVA-3S investigators.

Lancet Neurol. 2008 Oct;7(10):885-92. doi: 10.1016/S1474-4422(08)70195-9. Epub 2008 Sep 5.

PMID:
18774745
48.

Pyrrolocarbazoles as checkpoint 1 kinase inhibitors.

Hénon H, Conchon E, Hugon B, Messaoudi S, Golsteyn RM, Prudhomme M.

Anticancer Agents Med Chem. 2008 Aug;8(6):577-97. Review.

PMID:
18690823
49.

[Update on vascular dementias].

Auriacombe S, Amarenco P, Baron JC, Ceccaldi M, Dartigues JF, Lehéricy S, Hénon H, Hinaut P, Orgogozo JM; Groupe de consensus Théma.

Rev Neurol (Paris). 2008 Jan;164(1):22-41. doi: 10.1016/j.neurol.2007.06.001. Epub 2008 Feb 20. Review. French.

PMID:
18342055
50.

Early epileptic seizures after stroke are associated with increased risk of new-onset dementia.

Cordonnier C, Hénon H, Derambure P, Pasquier F, Leys D.

J Neurol Neurosurg Psychiatry. 2007 May;78(5):514-6.

Supplemental Content

Support Center